Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA)

Q: What does CUSIP 640979100 represent in this 13F holders report?

CUSIP 640979100 is the security identifier for NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q1 2025?

111 institutional investors reported NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 640979100

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 65,233,736
Total 13F value: $65,235,367
Share change: -15,269,200
Put/Call ratio: 58%
SEC-reported price per share: $1.00
Number of holders: 111
Value change: -$163,396,114
Number of buys: 59
Number of sells: 79
Shares outstanding: 186,788,806

Security key

640979100

Report period

Q1 2025

Institutions

111

Top holders

NMRA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Neumora Therapeutics, Inc. SEC filings Neumora Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 640979100

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Paul L. Berns

Disclosed value leader

AMGEN INC

Comparable rows

2/15

Latest evidence

31 Dec 2024

13D/G 13F 3/4/5 Lead comparable stake: 5.1% 13 rows are not safely comparable across share classes. 13D/G row: Paul L. Berns Showing 1-6 of 15 holder rows.

Quick read

Paul L. Berns leads the comparable SEC ownership view at 5.1%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Paul L. Berns's linked filing trail.

Comparable ownership Top 2

Paul L. Berns 5.1%

FMR LLC 2.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Paul L. Berns	13D/G 13D/G	5.1% Reported 13D/G · 31 Dec 2024	$6,334,229 8,226,272 shares	$0	31 Dec 2024
FMR LLC	13F 13D/G 3/4/5 Company · Other* 13F 13D/G 3/4/5	2.2% Reported 13D/G · 31 Mar 2025	$83,088,916 7,838,577 shares	—	31 Dec 2024
AMGEN INC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$423,716,463 35,368,653 shares	—	19 Sep 2023
BlackRock, Inc.	13F Company 13F	— denominator unverified	$75,334,159 7,106,996 shares	—	31 Dec 2024
SOFTBANK GROUP CORP.	13F Company 13F	— denominator unverified	$69,336,614 6,541,190 shares	—	31 Dec 2024
T. Rowe Price Investment Management, Inc.	13F Company 13F	— denominator unverified	$53,030,000 5,002,799 shares	—	31 Dec 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

111

65,233,736

Rows available

111

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders

111

Q1 2025 holders

111

Holder diff

Investor	Q1 2025 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend